ZIM Integrated Shipping: Soaring Container Rates Spark More Acquisition Interest
Developing story — details emerging. Check the source link for the latest updates.
Developing story — details emerging. Check the source link for the latest updates.
Developing story — details emerging. Check the source link for the latest updates.
2 points, 0 comments on Hacker News
3 points, 0 comments on Hacker News
Developing story — details emerging. Check the source link for the latest updates.
Nuvalent’s late-stage lung cancer treatments zidesamtinib and neladalkib are expected to launch later this year Business live – latest updates GSK’s new boss, Luke Miels , has struck one of the British drugmaker’s biggest deals, announcing the $10. 6bn (£7. 9bn) acquisition of a US cancer special...